1. Academic Validation
  2. Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK

Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK

  • Diabetes. 2005 Apr;54(4):1074-81. doi: 10.2337/diabetes.54.4.1074.
Warren C Ladiges 1 Sue E Knoblaugh John F Morton Marcus J Korth Bryce L Sopher Carole R Baskin Alasdair MacAuley Alan G Goodman Renee C LeBoeuf Michael G Katze
Affiliations

Affiliation

  • 1 Department of Comparative Medicine, Comparative Mouse Genomics Center, University of Washington, Seattle, Washington 98195, USA. wladiges@u.washington.edu
Abstract

The endoplasmic reticulum (ER) transmits apoptotic signals in the pancreas during ER stress, implicating ER stress-mediated Apoptosis in the development of diabetes. P58(IPK) (DNAJC3) is induced during ER stress and functions as a negative feedback component to inhibit eIF-2alpha signaling and attenuate the later phases of the ER stress response. To gain insight into a more comprehensive role of P58(IPK) function, we generated deletion mutant mice that showed a gradual onset of glucosuria and hyperglycemia associated with increasing Apoptosis of pancreatic islet cells. Lack of P58(IPK) had no apparent effect on the functional integrity of viable beta-cells. A set of genes associated with Apoptosis showed altered expression in pancreatic islets from P58(IPK)-null mice, further substantiating the Apoptosis phenotype. The data provide in vivo evidence to support the concept that P58(IPK) functions as a signal for the downregulation of ER-associated proteins involved in the initial ER stress response, thus preventing excessive cell loss by degradation pathways. Insulin deficiency associated with the absence of P58(IPK) mimics beta-cell failure associated with type 1 and late-stage type 2 diabetes. P58(IPK) function and activity may therefore provide a novel area of investigation into ER-mediated mechanistic and therapeutic approaches for diabetes.

Figures